ICH harmonised guideline integrated addendum to ICH E6(R1): Guideline for Good Clinical Practice ICH E6(R2)

INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE (ICH)

A standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected. Ethical and scientific quality standards for designing, conducting, recording and reporting trials that involve participation of human subjects to ensure that the rights, safety and wellbeing of the trial subjects are protected. Ensure the credibility of clinical trial data.

TABLE OF CONTENTS

INTRODUCTION TO ICH GCP 

1. GLOSSARY 

2. THE PRINCIPLES OF ICH GCP 

3. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) 

4. INVESTIGATOR 

5. SPONSOR 

6. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S) 

7. INVESTIGATOR’S BROCHURE 

8. ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL 

 

Source: European Medicines Agency, 2018

Clinical Research News

ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
Applying for a Paediatric investigation plan (PIP): review of the EMA guidelines
Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers

Upcoming Clinical Trials

Clinical Research Jobs

All jobs

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe